Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
active pharmaceutical ingredients
Pharma
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
In a new lawsuit, Teva flagged Amarin’s “anti-competitive conduct to prevent and delay generic competition” to Vascepa—a fish-oil-derived heart med.
Fraiser Kansteiner
Mar 29, 2024 1:10pm
EuroAPI taps new CEO as it embarks on restructuring campaign
Feb 28, 2024 3:40pm
China's API firm Sichuan Deebio in deep trouble with the FDA
Feb 12, 2024 2:46pm
Bain Capital eyes potential €1B Centrient sale: report
Jan 4, 2024 9:35am
Xellia to axe 80 positions at Ohio plant previously owned by BI
Dec 13, 2023 9:19am
Novo invests $6B as CEO indicates more expansion to come
Nov 10, 2023 10:30am